Riskpilot← Back to searchSign inGet full accessEbbameta AB
ABActiveOrg 5569967648Grev Turegatan 59 CMedical specialists activities · NACE 8622Est. 20140 employees
Revenue 2024
SEK 0
EBITDA margin
—
-7% vs 2023
Equity ratio
99.7%
Financial strength
Net profit 2024
SEK -3K
-110% vs 2023
| Revenue | SEK 0 | — |
| EBITDA | SEK -15K | -7% |
| Net profit | SEK -3K | -110% |
| Total assets | SEK 1,5M | -12% |
| Equity | SEK 1,5M | -12% |
| Employees | 0 | — |
Legal name
Ebbameta AB
Org number
5569967648
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
17 december 2014
Share capital
SEK 50 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Konsultverksamhet inom sjukvård, hudvård, kosmetik och friskvård.
Address
Grev Turegatan 59 C
Email
meta.svensson@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 8 | 0 | 0 | 0 | 0 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 1 | −14 | −16 | −14 | −15 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | 1 | −14 | −16 | −14 | −15 |
| Net financials | 2 939 | — | 30 | 49 | 12 |
| Profit before tax | 2 940 | −14 | 14 | 35 | −3 |
| Tax | −0 | −0 | −0 | −4 | −0 |
| Net profit | 2 940 | −14 | 14 | 31 | −3 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 2 991 | 2 793 | 1 907 | 1 745 | 1 536 |
| Equity | 2 982 | 2 788 | 1 902 | 1 738 | 1 531 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 9 | 5 | 5 | 7 | 5 |
| Total debt | 9 | 5 | 5 | 7 | 5 |
EBITDA margin
-1500000.0%
This company
15.8%
Market median
-9493771% vs market
20202024
Equity ratio
99.7%
This company
38.2%
Market median
+161% vs market
20202024
Return on equity
-0.2%
This company
18.4%
Market median
-101% vs market
20202024
Net profit margin
-300000.0%
This company
8.1%
Market median
-3703804% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
| Former (1) | ||
| Board of Directors | 2022 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Ebbameta AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Mats Svensson | Board of Directors | 0 companies |
| Eva Camilla Svensson | Deputy Board Member | 0 companies |
| Meta Ebba Margaretha Svensson | Board of Directors | 0 companies |